logo
welcome
The Motley Fool

The Motley Fool

Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom

The Motley Fool
Summary
Nutrition label

75% Informative

Novo Nordisk's Wegovy was recently granted an expanded indication from the Food and Drug Administration ( FDA ) to treat cardiovascular disease in obesity patients.

Eli Lilly has two leading GLP-1 medicines, Mounjaro and Zepbound .

The company's oral solution, orforglipron , is currently in phase 3 clinical trials.

In July , the company received FDA approval for its Alzheimer's disease candidate.

The 10 stocks that made the cut could produce monster returns in the coming years .

Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 710,860 ! The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002 .

VR Score

68

Informative language

63

Neutral language

41

Article tone

formal

Language

English

Language complexity

47

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

7

https://www.fool.com/author/20479/https://www.fool.com/legal/fool-disclosure-policy/https://www.fool.com/investing/2024/09/22/investing-in-this-healthcare-stock-could-be-like/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=75688538-9647-44ab-8e49-06c059aaed4bhttps://www.fool.com/investing/2024/08/30/think-eli-lilly-stock-has-peaked-these-10-words/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=75688538-9647-44ab-8e49-06c059aaed4bhttps://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=74eda937-402b-4cc6-99c7-a4540778e744&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D10993%26source%3Disaeditxt0010951%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D16425%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DEli%2520Lilly&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=75688538-9647-44ab-8e49-06c059aaed4bhttps://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=74eda937-402b-4cc6-99c7-a4540778e744&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D10993%26source%3Disaeditxt0010951%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D16425&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=75688538-9647-44ab-8e49-06c059aaed4bhttps://www.fool.com/terms/b/blockbuster-drug/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=75688538-9647-44ab-8e49-06c059aaed4b

Source diversity

2

Affiliate links

no affiliate links